Awards & Advancement

Array BioPharma names Michael Needle as chief medical officer

Friday, March 22, 2013 11:14 AM

Array BioPharma, a biopharmaceutical company focused on targeted small molecule drugs to treat cancer, has appointed Michael N. Needle, M.D., as its chief medical officer. 

More... »

INC Research appoints James Taylor as vice president of clinical development

Tuesday, March 19, 2013 08:00 AM

INC Research, a therapeutically focused global CRO, has appointed James Taylor as vice president of clinical development.

More... »

New York Genome Center Announces Change in Executive Leadership

Monday, March 18, 2013 09:59 AM

Nancy J. Kelley, founding executive director of the New York Genome Center (NYGC), an independent, non-profit organization that leverages the collaborative resources of leading academic medical centers, research universities and commercial organizations, will depart from her position with NYGC. She will remain an advisor and a member of the board of directors.

More... »

Chimerix appoints Michael Rogers as chief development officer

Monday, March 18, 2013 09:40 AM

Chimerix, a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, has appointed Michael D. Rogers, Ph.D., as chief development officer.

More... »

Parexel CEO Rickenbach to receive MassBio’s Henri Termeer Innovative Leadership Award

Monday, March 11, 2013 02:35 PM

Josef von Rickenbach, chairman and CEO of Parexel International, a global bio/pharmaceutical services organization, will be honored for his commitment and contributions to the biotechnology industry, by the Massachusetts Biotechnology Council (MassBio), a not-for-profit organization that represents and provides services and support for the Massachusetts biotechnology industry.

More... »

Leukemia & Lymphoma Society expands chief policy, advocacy officer role

Friday, March 8, 2013 10:34 AM

The Leukemia & Lymphoma Society (LLS) has expanded the role of chief policy and advocacy officer Mark Velleca, M.D., Ph.D. Velleca, who has headed LLS' Office of Public Policy in Washington, D.C., since early 2012, will now oversee the newly integrated patient advocacy, policy and programs department.

More... »

Sitrof promotes Kivlehan to director of mobility and collaboration

Thursday, March 7, 2013 01:43 PM

Princeton, N.J.-based Sitrof Technologies, a developer of content management, process harmonization and compliance solutions for the life sciences industry, has promoted Thomas Kivlehan to director, mobility and collaboration.

More... »

Personal Genome Diagnostics hires chief commercial officer

Thursday, March 7, 2013 01:41 PM

Baltimore-based Personal Genome Diagnostics (PGDx), a pioneer in conducting patient-specific analyses aimed at identifying genomic alterations in tumors, has recruited veteran industry executive Antony Newton as it prepares for accelerated growth.

More... »

Delta Point hires former AstraZeneca exec Michael Hickey

Thursday, March 7, 2013 01:40 PM

Michael Hickey, former vice president of U.S. sales at AstraZeneca and former president of AstraZeneca, Netherlands, has joined Delta Point of Malvern, Pa., as senior vice president of global leadership development.

More... »

Marken appoints two independent directors to board

Tuesday, March 5, 2013 04:10 PM

Marken, based in Research Triangle Park, N.C., has appointed two independent directors to its board, as a result of Marken's recent restructuring completed Dec. 21, 2012.  They are Timothy C. Tyson and Michael O'Donnell.

More... »